Literature DB >> 21412713

The diagnosis of Amyotrophic lateral sclerosis in 2010.

Vincenzo Silani1, Stefano Messina, Barbara Poletti, Claudia Morelli, Alberto Doretti, Nicola Ticozzi, Luca Maderna.   

Abstract

The diagnosis of Amyotrophic lateral sclerosis (ALS) remains in 2010 clinical with neurophysiological support in absence of specific biomarker(s). The disease is diverse in its presentation, cause, and progression. Treatable mimic syndromes must be excluded before the diagnosis is ascribed: ALS and its variants are recognized by neurologists, but 10% of patients are misdiagnosed. Delays in diagnosis are common. Less than 10% of cases are familial and associated with several interactive genes. The onset of ALS predates development of the clinical symptoms by an unknown interval which may extend several years. Prompt diagnosis, sensitive communication of the diagnosis, the involvement of the patient and family, a positive care plan are pre-requisites for the good clinical management of ALS patients.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21412713     DOI: 10.4449/aib.v149i1.1260

Source DB:  PubMed          Journal:  Arch Ital Biol        ISSN: 0003-9829            Impact factor:   1.000


  16 in total

1.  Acetylcholine receptors from human muscle as pharmacological targets for ALS therapy.

Authors:  Eleonora Palma; Jorge Mauricio Reyes-Ruiz; Diego Lopergolo; Cristina Roseti; Cristina Bertollini; Gabriele Ruffolo; Pierangelo Cifelli; Emanuela Onesti; Cristina Limatola; Ricardo Miledi; Maurizio Inghilleri
Journal:  Proc Natl Acad Sci U S A       Date:  2016-02-29       Impact factor: 11.205

2.  Amyotrophic lateral sclerosis: update and new developments.

Authors:  Ashley J Pratt; Elizabeth D Getzoff; J Jefferson P Perry
Journal:  Degener Neurol Neuromuscul Dis       Date:  2012-02

3.  Comparative Magnetic Resonance Imaging and Histopathological Correlates in Two SOD1 Transgenic Mouse Models of Amyotrophic Lateral Sclerosis.

Authors:  Ilaria Caron; Edoardo Micotti; Alessandra Paladini; Giuseppe Merlino; Laura Plebani; Gianluigi Forloni; Michel Modo; Caterina Bendotti
Journal:  PLoS One       Date:  2015-07-01       Impact factor: 3.240

Review 4.  Nosology of juvenile muscular atrophy of distal upper extremity: from monomelic amyotrophy to Hirayama disease--Indian perspective.

Authors:  Kaukab Maqbool Hassan; Hirdesh Sahni
Journal:  Biomed Res Int       Date:  2013-08-26       Impact factor: 3.411

5.  Formal Semantics in the Neurology Clinic: Atypical Understanding of Aspectual Coercion in ALS Patients.

Authors:  Giosuè Baggio; Giulia Granello; Lorenzo Verriello; Roberto Eleopra
Journal:  Front Psychol       Date:  2016-11-04

6.  Plasma peptide biomarker discovery for amyotrophic lateral sclerosis by MALDI-TOF mass spectrometry profiling.

Authors:  Laurence Conraux; Catherine Pech; Halim Guerraoui; Denis Loyaux; Pascual Ferrara; Jean-Claude Guillemot; Vincent Meininger; Pierre-François Pradat; François Salachas; Gaëlle Bruneteau; Nadine Le Forestier; Lucette Lacomblez
Journal:  PLoS One       Date:  2013-11-05       Impact factor: 3.240

7.  The extracellular domain of neurotrophin receptor p75 as a candidate biomarker for amyotrophic lateral sclerosis.

Authors:  Stephanie R Shepheard; Tim Chataway; David W Schultz; Robert A Rush; Mary-Louise Rogers
Journal:  PLoS One       Date:  2014-01-27       Impact factor: 3.240

Review 8.  Role of PET and SPECT in the study of amyotrophic lateral sclerosis.

Authors:  Angelina Cistaro; Vincenzo Cuccurullo; Natale Quartuccio; Marco Pagani; Maria Consuelo Valentini; Luigi Mansi
Journal:  Biomed Res Int       Date:  2014-04-10       Impact factor: 3.411

9.  Fast skeletal muscle troponin activator tirasemtiv increases muscle function and performance in the B6SJL-SOD1G93A ALS mouse model.

Authors:  Darren T Hwee; Adam Kennedy; Julie Ryans; Alan J Russell; Zhiheng Jia; Aaron C Hinken; David J Morgans; Fady I Malik; Jeffrey R Jasper
Journal:  PLoS One       Date:  2014-05-07       Impact factor: 3.240

10.  Overstimulation of the inhibitory nervous system plays a role in the pathogenesis of neuromuscular and neurological diseases: a novel hypothesis.

Authors:  Bert Tuk
Journal:  F1000Res       Date:  2016-06-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.